DOCS Doximity
- Official Name: DOXIMITY, INC.
- Headquarters: 500 Third Street, Suite 510, SAN FRANCISCO, CA, 94107 US
- CEO: Jeffrey Tangney
- Website: doximity.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Won by 0.593 | (0.568) - (1.161) | ||
| 2025-07-15 | 1R | Won by 1.697 | (0.031) - (1.728) | ||
| 2025-07-22 | 2 | Lost by 8.726 | (4.500) - 4.226 | ||
| 2025-07-29 | 3 | Lost by 4.485 | 2.430 - 6.915 | ||
| 2025-07-29 | 2R | Lost by 3.105 | (2.337) - 0.768 | ||
| 2025-08-05 | 4 | Lost by 2.260 | (3.313) - (1.053) | ||
| 2025-08-12 | 5 | Won by 6.283 | 9.111 - 2.828 | ||
| 2025-08-19 | 6 | Lost by 0.300 | 2.328 - 2.628 | ||
| 2025-08-26 | 7 | Won by 7.838 | 5.576 - (2.262) | ||
| 2025-09-02 | 8 | Won by 1.234 | (0.119) - (1.353) | ||
| 2025-09-09 | 9 | Won by 3.246 | 4.033 - 0.787 | ||
| 2025-09-16 | 10 | Won by 11.974 | 4.416 - (7.558) | ||
| 2025-09-23 | 11 | Won by 11.215 | 2.704 - (8.511) | ||
| 2025-09-30 | 12 | Lost by 7.222 | (0.951) - 6.271 | ||
| 2025-10-07 | 13 | Lost by 2.608 | (2.363) - 0.245 | ||
| 2025-10-14 | 14 | Lost by 1.974 | (5.795) - (3.821) | ||
| 2025-10-21 | 15 | Lost by 6.411 | 1.351 - 7.762 |
Latest News

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026
SAN FRANCISCO, October 15, 2026--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will repo...

Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
DOCS extends its 13-year partnership with U.S. News, strengthening its role in physician searches, appointment booking and hospital rankings.

Doximity Reports Q1 2027 Results: Full Earnings Call Transcript
Doximity (NYSE:DOCS) released first-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga AP...

Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors
Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced it has extended its 13-year partnership with U.S. ...

Tempus AI Expands Strategic Collaborations to Drive Future Growth
TEM is expanding its precision medicine footprint through strategic collaborations with Moderna, Merck and Recursion, paving the way for future revenu...